Results 261 to 270 of about 429,046 (309)

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

Colchicine Use in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Cheong HC, Kuo MH, Tseng CW, Li YD.
europepmc   +1 more source

Vericiguat in patients with acute coronary syndrome and reduced ejection fraction: the EVE-ACSrEF study. [PDF]

BMC Cardiovasc Disord
Shi X, Zhao A, Ding Y, Gu L, Yang T, Wang H, Wang Q, Wang S, Wang L.   +8 more
europepmc   +1 more source

The Diagnostic Value of sdLDL-C for Acute Coronary Syndrome with Coexisting Hypertension and Carotid Atherosclerosis in Northeast China. [PDF]

Int J Gen Med
Li J, Dong Z, Wang D, Cui J.
europepmc   +1 more source

Prognostic Value of Estimated Glomerular Filtration Rate in Older Patients With Acute Coronary Syndrome. [PDF]

Rev Cardiovasc Med
Li Y, Sang T, Li Z, Lv N, Liu J, Gu Y, Han X, Zhang W, Dang A.   +8 more
europepmc   +1 more source

Case Report: The aslanger pattern as an indicator of severe acute coronary syndrome. [PDF]

Front Cardiovasc Med
Chen YZ, Yao ZY, Lin LW, Luo QY, Li R, Zhao XJ.   +5 more
europepmc   +1 more source

Temporal Expression of NLRP3 Inflammasome Components in Patients with Acute Coronary Syndrome. [PDF]

Life (Basel)
Papanikolaou P, Aggelopoulos A, Antonopoulos AS, Theofilis P, Gazouli M, Tsioufis K, Tousoulis D.   +6 more
europepmc   +1 more source